Featured Research

from universities, journals, and other organizations

Microchip Gives Blind Chance Of Sight

Date:
January 24, 2002
Source:
Office Of Naval Research
Summary:
A computer chip implanted near the eye’s retina is well on its way to offering some restored vision to people blinded by eye diseases such as retinitis pigmentosa and age-related degeneration of the eye. The implant works for eye diseases where healthy retinal neurons remain intact after they lose use of the eye’s photoreceptors that convert images into electric impulses.

A computer chip implanted near the eye’s retina is well on its way to offering some restored vision to people blinded by eye diseases such as retinitis pigmentosa and age-related degeneration of the eye. The implant works for eye diseases where healthy retinal neurons remain intact after they lose use of the eye’s photoreceptors that convert images into electric impulses.

Funded by the Office of Naval Research, researchers recently reported that tests show faces can be recognized and words in large type can be read. Human tests started recently. Dr. Mark Humayun, formerly of the Wilmer Ophthalmological Institute at Johns Hopkins University in Baltimore, is leading the research at the University of Southern California in Los Angeles.

To capture images, first an external camera mounted in an eyeglass frame captures the image and converts it into an electrical signal that is electronically transmitted to the flexible silicon biochip surgically attached near the retina. The chip electronically stimulates the healthy cells of the retina, which sends the signals conveying the image to the brain.


Story Source:

The above story is based on materials provided by Office Of Naval Research. Note: Materials may be edited for content and length.


Cite This Page:

Office Of Naval Research. "Microchip Gives Blind Chance Of Sight." ScienceDaily. ScienceDaily, 24 January 2002. <www.sciencedaily.com/releases/2002/01/020124174001.htm>.
Office Of Naval Research. (2002, January 24). Microchip Gives Blind Chance Of Sight. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/01/020124174001.htm
Office Of Naval Research. "Microchip Gives Blind Chance Of Sight." ScienceDaily. www.sciencedaily.com/releases/2002/01/020124174001.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins